Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma

FABP7 is overexpressed in ccRCC and promotes cell growth by the activation of ERK and Stat3 signaling pathways. Evidence from the clinical observations and experimental data suggests that FABP7 is a novel prognostic marker and potential therapeutic target for ccRCC.